Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

US9782407B2 · kind B2 · utility

Assignee

• DR. REDDY'S LABORATORIES LIMITED · IN

Inventors

• Anima Baruah · Hyderabad, IN
• Dibyendu De · Suwanee, US
• Ish Khanna · Vernon Hills, US
• Sivaram Pillarisetti · Norcross, US
• Santanu Maitra · Hyderabad, IN
• Christopher W. Alexander · Norcross, US
• Jennepalli Sreenu · Darsi, IN
• Indu Dager · Ghaziabad, IN
• Shanavas Alikunju · Darsi, IN

Key dates

• Filing date: Apr 15, 2015
• Grant date: Oct 10, 2017
• Expiry date: Apr 15, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.